Carbohydrate Loading Fasting Protocol Versus 'Sip Til Send'

April 1, 2025 updated by: Rana Muhammad Shoaib Sadiq, The Rotunda Hospital

Carbohydrate Loading Fasting Protocol Versus 'Sip Til Send': A Randomised Trial of Two Different Fasting Protocols at Elective Caesarean Delivery

Women undergoing elective caesarean deliveries are fasted for long periods prior to surgery. Recently, Rotunda Maternity Hospital have started using two fasting protocols at the Rotunda prior to elective caesarean section, one uses carbohydrate drinks, and the other encourages women to sip water until they are called to the operating theatre. The evidence to support the use of either one is very limited. This study would help streamline one of the protocols.

Study Overview

Detailed Description

This is a study focused on comparing fasting policies that are in use at the Rotunda.

Investigators wish to determine the best fasting policy for women at elective caesarean delivery by focusing on assessing outcomes related to the patient experience.

A 'Sip til send' fasting policy means women may drink clear fluid up until the time they are called from the ward to come to theatre for their elective caesarean delivery. This policy was implemented at the Rotunda in 2022 and was studied prospectively, investigators demonstrated improvements in the comfort that women experience in their perioperative journey, compared to a traditional fasting protocol where women must fast for many hours for both fluids and solids before they come to theatre.

It has been shown that oral carbohydrate intake may improve outcomes in general and cardiac surgeries, but there is very limited evidence in obstetrics. The Rotunda is increasingly providing women with carbohydrate drinks prior to CD. These drinks are consumed by the patient on the morning of surgery as part of an enhanced recovery after surgery (ERAS) package. There is little evidence to support the use of carbohydrate drinks, but current thinking is that they may increase energy and comfort and reduce metabolic changes due to prolonged fasting.

Pregnant women are more vulnerable to the side effects related to the extended fasting due to the accelerated fasting in the third trimester of pregnancy after an overnight fast pre-operatively. Carbohydrate reserves are rapidly exhausted, causing hypoglycemia, increased urine nitrogen secretion (indicating muscle catabolism), and increased urinary ketone body concentration. It has been recommended that Mothers in their third trimester avoid skipping meals.

Investigators wish to study the effects of integrating carbohydrate drinks into the current 'sip til send' fasting protocol and determine if these women benefit from either protocol.

Study Type

Interventional

Enrollment (Actual)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Dublin, Ireland
        • Rotunda Maternity Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Elective caesarean section for singleton pregnancy under neuraxial anaesthesia.
  • Subjects able to give informed consent and willing to comply with the study protocol.
  • Subjects must be greater than 18 years old

Exclusion Criteria:

  • Diabetes Mellitus - including gestational diabetes.
  • Known foetal abnormality.
  • Planned general anaesthesia.
  • Elective caesarean delivery at a gestation of less than 37 weeks.
  • Low birth weight 2.5 kg (IUGR)
  • BMI greater than 45 kg/m2
  • Women with severe gastro-oesophageal reflux disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Group C
fasting protocol consuming carbohydrate drinks before elective caesarean delivery and sipping water until called to theatre
Lemon flavoured clear carbohydrate drink
Active Comparator: Group S
fasting protocol NOT consuming carbohydrate drinks before elective caesarean delivery, but encouraged to sip water until called to theatre
clear fluid such as water

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
General well-being of the patient
Time Frame: Immediately Preoperatively
Compare fasting protocols using a 0-10 Visual Analogue Score (VAS) for patient-focused comfort outcomes, including anxiety, thirst, hunger, nausea, and comfort. Each of them would be scored from 0 to 10, 0 being nothing and 10 being the maximum score relative to the feeling
Immediately Preoperatively

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
General well-being of the patient
Time Frame: 24 hours post operative
  1. Intraoperative nausea and vomiting: Assessed as YES or NO
  2. Pre-operative urinary ketone level: Assessed with urine dipstick showing POSITIVE or NEGATIVE
  3. Pre-operative blood sugar level: Measured on glucometer in mmol/lt
  4. Quality of recovery score following ceaserean delivery (ObsQoR11) score at 24 hours: consists of 11 questions related to how the symptoms have been in the last 24 hours regarding pain, vomiting, dizziness, shivering, comfort level, mobility, and the requirement of assistance related to looking after one's self and the baby. Each aspect is measured from a scale of 0 to 10, 0 being minimal and 10 being maximum.
24 hours post operative

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 12, 2024

Primary Completion (Actual)

December 16, 2024

Study Completion (Actual)

December 16, 2024

Study Registration Dates

First Submitted

June 30, 2024

First Submitted That Met QC Criteria

July 15, 2024

First Posted (Actual)

July 17, 2024

Study Record Updates

Last Update Posted (Actual)

April 4, 2025

Last Update Submitted That Met QC Criteria

April 1, 2025

Last Verified

April 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • REC-2023-026

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Elective Cesarean Delivery

Clinical Trials on Pre op Carbohydrate drink

Subscribe